sickle cell anaemiaFactor V Leiden mutationPubMed comprises more than 22 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites....
Genetic study revealed factor V Leiden mutation and homozygous mutation G20210A in prothrombin gene. CONCLUSIONS: Both mutations found in this case, alone, are not a high risk factors for venous thrombosis but together may increase 5-10 fold risk of venous thrombosis. Venous stroke must be ...
Kyung A. Kang
Resistance to activated protein C (APC) is a common inherited risk factor for venous thrombosis, which is associated with a mutation in coagulation factor V (factor V Leiden). We investigated the risk of venous thrombosis in individuals homozygous for this abnormality. We determined the factor V...
Extensive hepatic infarction caused by thrombosis of right portal vein branches and arterial vasospasm in HELLP syndrome associated with homozygous factor ... (1998) Extensive hepatic infarction caused by thrombosis of right portal vein branches and arterial vasospasm in HELLP syndrome associated with ...
Risk of venous thromboembolism during pre- gnancy in homozygous carriers of the factor V Leiden muta- tion: are there any predictive factors? J Throm Haemost 2004; 2: 359-60.The Procare Group. Risk of venous thromboembolism during pregnancy in homozygous carriers of the factor V Leiden ...
Homozygous or double heterozygous factor V Leiden and/or prothrombin G20210A is a rare inherited thrombophilic trait. Whether individuals with this genetic background have an increased risk of recurrent venous thrombosis is uncertain.A case-control design within a large cohort of families with thrombop...
Factor V Leiden homozygous mutation: Recurrent venous thromboembolism during periods of discontinuation of anticoagulant therapydoi:10.17532/jhsci.2021.1283FACTOR V LeidenACTIVATED protein C resistanceTHROMBOEMBOLISMVENOUS thrombosisPULMONARY embolismDISEASE relapseVenous thromboembolism (VTE), also known...
(2000) Homozygous factor V Leiden mutation in a woman with multiple adverse pregnancy outcomes. Arch Gynecol Obstet 264(3), 164-5.Pauer HU, Neesen J, Schloesser M, Hinney B, Rauskolb R: Homozygous factor V Leiden mutation in a woman with multiple adverse pregnancy outcomes. Arch Gynecol ...
The rate of early and late fetal loss was assessed and was compared among factor V Leiden homozygous, factor V Leiden heterozygous, and noncarriers, and the impact of concomitant thrombophilic abnormalities was examined. Results show that risk of fetal loss is higher in women who were homozygous...